Trial Details

TERMINATED
Basic Information
Clinical ID c1222
Identifier NCT05382715
Trial Title A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Colitis, Ulcerative
Interventions DRUG: Ozanimod
Participant Information
Sponsor Bristol-Myers Squibb
City Berlin
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2022-05-30
Primary Completion Date 2025-05-31
Completion Date 2025-05-31